InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,010.60
(
0.87%
)
US TECH 100
16,795.20
(
0.25%
)
Dow Jones
38,239.98
(
0.67%
)
Brent Oil
87.19
(
0.90%
)
Bitcoin
66,162.58
(
-1.04%
)
Post# of 3833
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

gss2003

Send PM Follow Ignore
Followers 2
Posts 353
Boards Moderated 0
Alias Born 07/13/2007

gss2003

Re: biotechnician post# 2466

Wednesday, 09/28/2016 10:08:17 AM

Wednesday, September 28, 2016 10:08:17 AM

Post# of 3833
I think success would be more attributable to the trial design than anything, a 10% reduction in HVPG could warrant approval from listening to the conference call. Not that anything suggest GR-MD-02 can deliver that.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GALT News
More GALT News
InvestorsHub NewsWire

FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM

BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM

Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM

Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM

ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM

Start posting your company's news
Only $200 per official company press release!